search
Back to results

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
No choice given
Choice given
Ibuprofen
Acetaminophen
Gabapentin
Morphine (low)
Morphine (med)
Morphine (high)
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring cesarean, postoperative pain, patient choice

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women age 18-50
  • Singleton gestation
  • Not in active labor
  • Scheduled for their 1st, 2nd, or 3rd elective Cesarean
  • Cesarean deliveries under spinal or combined spinal epidural anesthesia (with no additional epidural doses administered)

Exclusion Criteria:

  • History of chronic pain, anxiety, or depression
  • Unable to understand the concept of Verbal Numerical Pain Scale at the time of informed consent
  • Chronic consumption of opiates, antidepressants or anticonvulsants
  • Intake of opioids, NSAIDS or acetaminophen 48hrs prior to the psychophysical test
  • Preeclampsia (with any severe features)
  • Diabetes (not controlled with diet and needing drugs)
  • Preterm delivery (<35 weeks gestation)

Sites / Locations

  • Lucille Packard Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Arm Label

No choice

Choice: low protocol

Choice: medium protocol

Choice: high protocol

Arm Description

No choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h

Choice given low dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h

Choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h

Choice given high dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h gabapentin po one time dose

Outcomes

Primary Outcome Measures

Opioid Consumption in the 0-48 Hour Study Periods.
Opioid consumption was measured in milligram morphine equivalents in the 0-24 and 24-48 hour study periods.
Pain Scores
Pain scores at rest and at movement post-cesarean delivery. Score was rated on a scale from 0 to 10, where 0=no pain and 10=worst imaginable pain.

Secondary Outcome Measures

Count of Participants Who Need Opioid Use
Count of participants who need opioid use through 48 hours after delivery.
Count of Participants With Presence of Pruritus
Count of participants with pruritus through 48 hours after delivery.
Pruritus Score at 24 and 48 After Delivery
Score was rated on a scale from 0 to 10, where 0=no itching and 10=most itching.
Count of Participants Who Need Medical Treatment of Pruritus
Count of participants who need medical treatment of pruritus during first 48 hours after delivery.
Counts of Participants With Presence of Nausea
Count of participants with nausea through 48 hours after delivery.
Nausea Score Score at 24 and 48 After Delivery
Score was rated on a scale from 0 to 10, where 0=no nausea and 10=most nausea.
Counts of Participants Who Need Medical Treatment for Nausea
Counts of participants who need medical treatment of nausea through 48 hours after delivery.
Average Number of Vomiting Episodes After Delivery
Time to Discharge
Minutes from delivery until discharge.
Patient Overall Satisfaction With Postoperative Analgesia
Score was rated on a scale from 0 to 100, where 0=completely unsatisfied and 100=completely satisfied.

Full Information

First Posted
November 10, 2015
Last Updated
September 17, 2018
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT02605187
Brief Title
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
Official Title
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
November 2015 (Actual)
Primary Completion Date
May 22, 2017 (Actual)
Study Completion Date
May 22, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.
Detailed Description
This randomized, controlled study will include a simple, preoperative questionnaire to obtain baseline demographic and obstetric data; and complete questions (that have previously been shown to be predictive of postoperative pain) from which we will determine their expected and target postoperative pain scores. These questionnaires should take less than 3-4 minutes to complete. The subject will then be randomized into "choice" and "no choice" groups. The randomization for choice vs. no choice will be at a 1:3 ratio i.e. 1 woman will get no choice and 3 will get a choice for their analgesic protocol. All women will receive the same medications for intraoperative anesthetic management -- only the postoperative pain medications will be altered. The no choice group will receive the current standard analgesic protocol: medium dose intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po q6h. The group with the choice will be offered 3 different protocols: 1. low dose intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po q6h. 2 medium dose intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po q6h. 3. high dose intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po q6h, as well as gabapentin po one time within 1 hr of delivery. Women randomized to the "choice" group will select a protocol after being given a standard script explaining advantages and disadvantages of each protocol. Drugs and doses utilized in the study are safe for postpartum women and within dose range routinely used at our and other institutions. All breakthrough pain will be managed the same for all patients, and adequate analgesia will be available to treat post-operative pain. Primary breakthrough rescue analgesic will be our standard oral opioid oxycodone managed using our current treatment algorithm. If pain 1-4 out of 10, 1 tablet (5 mg) will be offered, if pain >4 out of 10, 2 tablets (10 mg) will be offered PRN. Pain not responding to oral opioids will be offered IV morphine boluses or PCA as per standard treatment protocols. Additional analgesic options (e.g. TAP blocks) will also be available as per standard care. Following standard Cesarean delivery, postoperative data will be collected (directly from patients and from the electronic medical record) by study investigators blinded to group assignment. Outcome measures: Pain scores at rest and on to sitting (VPS 0-10) collected at 3, 6, 12, 24, 36, 48 hours post-cesarean Overall daily pain score and its deviation from target and expected pain score will be determined at 0-24 and >24-48 hours study periods. Opioid use (oral and IV morphine) in the 0-24 and >24-48 hour study periods. Time to first analgesic for breakthrough pain (minutes from spinal) Side effect: Pruritus score (0-100), nausea score (0-100) and number of episodes of vomiting for the 0-24 and >24-48 hour post- operative periods Any treatment of pruritus and/or nausea/vomiting Satisfaction with postoperative analgesia score (0-100) Discharge time (hours/minutes from surgery end) Telephone follow-up for pain score, opioid use, and functional recovery will be performed at 1 week, 1 month, 3 months and 6 months post-Cesarean. The telephonic questions will last 3-4 minutes

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
cesarean, postoperative pain, patient choice

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Actual)

8. Arms, Groups, and Interventions

Arm Title
No choice
Arm Type
Active Comparator
Arm Description
No choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h
Arm Title
Choice: low protocol
Arm Type
Experimental
Arm Description
Choice given low dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h
Arm Title
Choice: medium protocol
Arm Type
Experimental
Arm Description
Choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h
Arm Title
Choice: high protocol
Arm Type
Experimental
Arm Description
Choice given high dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h gabapentin po one time dose
Intervention Type
Other
Intervention Name(s)
No choice given
Intervention Description
Patients are randomized to getting a choice or not getting a choice. If they do not get a choice, they receive standard dose.
Intervention Type
Other
Intervention Name(s)
Choice given
Intervention Description
Patients are randomized to getting a choice or not getting a choice. If they do get a choice, they will receive the protocol they select.
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Intervention Description
Ibuprofen 600mg po q6h
Intervention Type
Drug
Intervention Name(s)
Acetaminophen
Intervention Description
Acetaminophen 650mg po q6h
Intervention Type
Drug
Intervention Name(s)
Gabapentin
Intervention Description
Gabapentin 600mg po one time within 1 hour of delivery
Intervention Type
Drug
Intervention Name(s)
Morphine (low)
Other Intervention Name(s)
Low dose morphine
Intervention Description
Intrathecal morphine dose 50mcg
Intervention Type
Drug
Intervention Name(s)
Morphine (med)
Other Intervention Name(s)
Medium dose morphine
Intervention Description
Intrathecal morphine dose 150mcg
Intervention Type
Drug
Intervention Name(s)
Morphine (high)
Other Intervention Name(s)
High dose morphine
Intervention Description
Intrathecal morphine 300mcg
Primary Outcome Measure Information:
Title
Opioid Consumption in the 0-48 Hour Study Periods.
Description
Opioid consumption was measured in milligram morphine equivalents in the 0-24 and 24-48 hour study periods.
Time Frame
0-24 and 24-48 hour postoperative periods
Title
Pain Scores
Description
Pain scores at rest and at movement post-cesarean delivery. Score was rated on a scale from 0 to 10, where 0=no pain and 10=worst imaginable pain.
Time Frame
3, 6, 12, 24, 36 and 48 hours after delivery
Secondary Outcome Measure Information:
Title
Count of Participants Who Need Opioid Use
Description
Count of participants who need opioid use through 48 hours after delivery.
Time Frame
0-24 and 24-48 hours after delivery
Title
Count of Participants With Presence of Pruritus
Description
Count of participants with pruritus through 48 hours after delivery.
Time Frame
0-24 and 24-48 hours after delivery
Title
Pruritus Score at 24 and 48 After Delivery
Description
Score was rated on a scale from 0 to 10, where 0=no itching and 10=most itching.
Time Frame
24 and 48 hours following delivery
Title
Count of Participants Who Need Medical Treatment of Pruritus
Description
Count of participants who need medical treatment of pruritus during first 48 hours after delivery.
Time Frame
0-24 and 24-48 hours after delivery
Title
Counts of Participants With Presence of Nausea
Description
Count of participants with nausea through 48 hours after delivery.
Time Frame
0-48 hours after delivery
Title
Nausea Score Score at 24 and 48 After Delivery
Description
Score was rated on a scale from 0 to 10, where 0=no nausea and 10=most nausea.
Time Frame
0-24 and 24-48 hours after delivery
Title
Counts of Participants Who Need Medical Treatment for Nausea
Description
Counts of participants who need medical treatment of nausea through 48 hours after delivery.
Time Frame
0-24 and 24-48 hours after delivery
Title
Average Number of Vomiting Episodes After Delivery
Time Frame
0-24 and 24-48 hours after delivery
Title
Time to Discharge
Description
Minutes from delivery until discharge.
Time Frame
Delivery through discharge (average 4 days)
Title
Patient Overall Satisfaction With Postoperative Analgesia
Description
Score was rated on a scale from 0 to 100, where 0=completely unsatisfied and 100=completely satisfied.
Time Frame
24 and 48 hours after delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women age 18-50 Singleton gestation Not in active labor Scheduled for their 1st, 2nd, or 3rd elective Cesarean Cesarean deliveries under spinal or combined spinal epidural anesthesia (with no additional epidural doses administered) Exclusion Criteria: History of chronic pain, anxiety, or depression Unable to understand the concept of Verbal Numerical Pain Scale at the time of informed consent Chronic consumption of opiates, antidepressants or anticonvulsants Intake of opioids, NSAIDS or acetaminophen 48hrs prior to the psychophysical test Preeclampsia (with any severe features) Diabetes (not controlled with diet and needing drugs) Preterm delivery (<35 weeks gestation)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brendan Carvalho, MBBCh, MDCH
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lucille Packard Children's Hospital
City
Palo Alto
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
23249931
Citation
Eisenach JC, Pan P, Smiley RM, Lavand'homme P, Landau R, Houle TT. Resolution of pain after childbirth. Anesthesiology. 2013 Jan;118(1):143-51. doi: 10.1097/ALN.0b013e318278ccfd.
Results Reference
background
PubMed Identifier
18818022
Citation
Eisenach JC, Pan PH, Smiley R, Lavand'homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008 Nov 15;140(1):87-94. doi: 10.1016/j.pain.2008.07.011. Epub 2008 Sep 24.
Results Reference
background
PubMed Identifier
16698416
Citation
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. doi: 10.1016/S0140-6736(06)68700-X.
Results Reference
background
PubMed Identifier
16960491
Citation
Lavand'homme P. Perioperative pain. Curr Opin Anaesthesiol. 2006 Oct;19(5):556-61. doi: 10.1097/01.aco.0000245284.53152.1f.
Results Reference
background
PubMed Identifier
30867278
Citation
Carvalho B, Sutton CD, Kowalczyk JJ, Flood PD. Impact of patient choice for different postcesarean delivery analgesic protocols on opioid consumption: a randomized prospective clinical trial. Reg Anesth Pain Med. 2019 May;44(5):578-585. doi: 10.1136/rapm-2018-100206. Epub 2019 Mar 13.
Results Reference
derived

Learn more about this trial

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

We'll reach out to this number within 24 hrs